Observational studyClinical immunology (Orlando, Fla.)2021

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.

Hèctor Corominas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.